Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2003
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/31/2003CA2485537A1 Novel compounds, their use and preparation
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670451 Netrins
12/30/2003US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide;
12/30/2003US6670399 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670371 Antagonists of Corticotropin-Releasing Factor
12/30/2003US6670369 Use of phanquinone for the treatment of alzheimer's disease
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670359 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders
12/30/2003US6670358 Substituted thioacetamides
12/30/2003US6670356 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
12/30/2003US6670349 Asthma
12/30/2003US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone
12/30/2003US6670340 6-Mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
12/30/2003US6670138 Method of diagnosing ischemic stroke via UCP-2 detection
12/30/2003US6670137 Differential diagnosis of neurological diseases
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists
12/30/2003CA2291931C Isochroman compounds and their production process
12/30/2003CA2291732C A salt (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxaminde hydrogen (2r,3r)-tartrate
12/30/2003CA2146723C Percutaneous absorption preparation
12/30/2003CA2132976C Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
12/30/2003CA2051399C Therapeutically useful 2-aminotetralin derivatives
12/30/2003CA2040086C Novel 2,9-disubstituted-4h-pyrido[1,2-a]pyrimidin-4-ones
12/26/2003CA2391691A1 Modified release pharmaceutical composition containing bupropion hci as active substance
12/25/2003US20030236429 Process for the production of chiral compounds
12/25/2003US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors
12/25/2003US20030236405 7-hetero-bicyclo[2.2.1]-heptanes
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236309 Novel formate salt of O-desmethyl-venlafaxine
12/25/2003US20030236304 Fluorobenzamides and uses thereof
12/25/2003US20030236303 Therapeutic compositions and methods of use
12/25/2003US20030236295 Tricylic indole compounds having affinity for serotonin receptor
12/25/2003US20030236289 Antiinflammatory agents; analgesics; antipyretics; cyclooxygenase inhibitor
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
12/25/2003US20030236281 Quinoline derivatives(2)
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/25/2003US20030236279 Central nervous system disorders; psychological disorders
12/25/2003US20030236278 Serotonine receptors antagonist; central nervous system disorders
12/25/2003US20030236273 Aryl substituted pyrimidines and the use thereof
12/25/2003US20030236270 Central nervous system disorders
12/25/2003US20030236269 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
12/25/2003US20030236268 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
12/25/2003US20030236267 Benzimidazole derivatives
12/25/2003US20030236264 Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236253 Gabapentin; antiepileptic agents, analgesics
12/25/2003US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030236248 Kappa agonist compounds and pharmaceutical formulations thereof
12/25/2003US20030236245 Helix mimetics and composition and methods related thereto
12/25/2003US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
12/25/2003US20030236240 Macrocycles useful in the treatment of alzheimer's disease
12/25/2003US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal
12/25/2003US20030236222 For the prevention and/or treatment of motoneuron diseases
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236202 Natural products and derivatives thereof for protection against neurodegenerative diseases
12/25/2003US20030236200 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
12/25/2003US20030236199 Mycrocycles useful in the teatment of Alzheimer's disease
12/25/2003US20030236197 Modulators of beta-amyloid peptide aggregation
12/25/2003US20030235897 Immunological control of beta-amyloid levels in vivo
12/25/2003US20030235631 Administering mixtures of phosphodiesterase inhibitors, anxiolytic agents and antidepressants for prophylaxis of psycholical disorders; efficiency
12/25/2003US20030235609 Use of cholinesterase antagonists to treat insulin resistance
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/25/2003US20030235563 Placental derived stem cells and uses thereof
12/25/2003US20030235558 Contacting a compound with a sample containing p62 and ubiquitin, determining level of p62/ubiquitin binding under normal conditions and in the presence of the compound and comparing the two levels
12/25/2003US20030235537 Pulmonary delivery in treating disorders of the central nervous system
12/25/2003US20030235535 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions
12/24/2003WO2003106683A1 Novel screening method
12/24/2003WO2003106669A1 Purified pkb ser 473 kinase and uses thereof
12/24/2003WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003WO2003106456A2 New compounds
12/24/2003WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003WO2003106452A2 Antagonists of melanin concentrating hormone receptor
12/24/2003WO2003106449A1 Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments
12/24/2003WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
12/24/2003WO2003106444A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
12/24/2003WO2003106441A1 Pharmaceutical salts of reboxetine
12/24/2003WO2003106439A1 Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation
12/24/2003WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003WO2003106430A1 Benzimidazole inhibitors of poly(adp-ribosyl) polymerase
12/24/2003WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents
12/24/2003WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
1 ... 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 ... 1833